SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GBT who wrote (62379)3/17/1999 10:00:00 AM
From: SpinCity1  Read Replies (1) of 119973
 
CYPB A GOOD BUY RIGHT NOW!

I HEARD ABOUT THIS ON ABC (I THINK , I CONFESS WAS SURFING) NEWS THIS AM

San Diego, March 17 (Bloomberg) -- Cypress Bioscience Inc. said it received government clearance to sell a blood filtering treatment used to ease the pain and inflammation caused by rheumatoid arthritis.

The U.S. Food and Drug Administration clearance sent Cyporess shares up as much as 27 percent in trading before the opening of U.S. markets. The action frees the company to try and carve a niche in the growing rheumatoid arthritis market, which analysts say could top $2 billion.

And for rheumatoid patients -- 40 percent of whom are debilitated so quickly they cannot work within 6 years -- the device could offer a crucial new option.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext